Wendy C Moore1, Annette T Hastie2, Xingnan Li2, Huashi Li2, William W Busse3, Nizar N Jarjour3, Sally E Wenzel4, Stephen P Peters2, Deborah A Meyers2, Eugene R Bleecker2. 1. Wake Forest School of Medicine, Center for Genomics and Personalized Medicine Research and the Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases, Winston-Salem, NC. Electronic address: wmoore@wakehealth.edu. 2. Wake Forest School of Medicine, Center for Genomics and Personalized Medicine Research and the Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases, Winston-Salem, NC. 3. University of Wisconsin School of Medicine and Public Health, Allergy, Pulmonary and Critical Care Division, Madison, Wis. 4. University of Pittsburgh School of Medicine, Pulmonary, Allergy and Critical Care Medicine, Pittsburgh, Pa.
Abstract
BACKGROUND: Clinical cluster analysis from the Severe Asthma Research Program (SARP) identified 5 asthma subphenotypes that represent the severity spectrum of early-onset allergic asthma, late-onset severe asthma, and severe asthma with chronic obstructive pulmonary disease characteristics. Analysis of induced sputum from a subset of SARP subjects showed 4 sputum inflammatory cellular patterns. Subjects with concurrent increases in eosinophil (≥2%) and neutrophil (≥40%) percentages had characteristics of very severe asthma. OBJECTIVE: To better understand interactions between inflammation and clinical subphenotypes, we integrated inflammatory cellular measures and clinical variables in a new cluster analysis. METHODS: Participants in SARP who underwent sputum induction at 3 clinical sites were included in this analysis (n = 423). Fifteen variables, including clinical characteristics and blood and sputum inflammatory cell assessments, were selected using factor analysis for unsupervised cluster analysis. RESULTS: Four phenotypic clusters were identified. Cluster A (n = 132) and B (n = 127) subjects had mild-to-moderate early-onset allergic asthma with paucigranulocytic or eosinophilic sputum inflammatory cell patterns. In contrast, these inflammatory patterns were present in only 7% of cluster C (n = 117) and D (n = 47) subjects who had moderate-to-severe asthma with frequent health care use despite treatment with high doses of inhaled or oral corticosteroids and, in cluster D, reduced lung function. The majority of these subjects (>83%) had sputum neutrophilia either alone or with concurrent sputum eosinophilia. Baseline lung function and sputum neutrophil percentages were the most important variables determining cluster assignment. CONCLUSION: This multivariate approach identified 4 asthma subphenotypes representing the severity spectrum from mild-to-moderate allergic asthma with minimal or eosinophil-predominant sputum inflammation to moderate-to-severe asthma with neutrophil-predominant or mixed granulocytic inflammation. Published by Mosby, Inc.
BACKGROUND: Clinical cluster analysis from the Severe Asthma Research Program (SARP) identified 5 asthma subphenotypes that represent the severity spectrum of early-onset allergic asthma, late-onset severe asthma, and severe asthma with chronic obstructive pulmonary disease characteristics. Analysis of induced sputum from a subset of SARP subjects showed 4 sputum inflammatory cellular patterns. Subjects with concurrent increases in eosinophil (≥2%) and neutrophil (≥40%) percentages had characteristics of very severe asthma. OBJECTIVE: To better understand interactions between inflammation and clinical subphenotypes, we integrated inflammatory cellular measures and clinical variables in a new cluster analysis. METHODS:Participants in SARP who underwent sputum induction at 3 clinical sites were included in this analysis (n = 423). Fifteen variables, including clinical characteristics and blood and sputum inflammatory cell assessments, were selected using factor analysis for unsupervised cluster analysis. RESULTS: Four phenotypic clusters were identified. Cluster A (n = 132) and B (n = 127) subjects had mild-to-moderate early-onset allergic asthma with paucigranulocytic or eosinophilic sputum inflammatory cell patterns. In contrast, these inflammatory patterns were present in only 7% of cluster C (n = 117) and D (n = 47) subjects who had moderate-to-severe asthma with frequent health care use despite treatment with high doses of inhaled or oral corticosteroids and, in cluster D, reduced lung function. The majority of these subjects (>83%) had sputum neutrophilia either alone or with concurrent sputum eosinophilia. Baseline lung function and sputum neutrophil percentages were the most important variables determining cluster assignment. CONCLUSION: This multivariate approach identified 4 asthma subphenotypes representing the severity spectrum from mild-to-moderate allergic asthma with minimal or eosinophil-predominant sputum inflammation to moderate-to-severe asthma with neutrophil-predominant or mixed granulocytic inflammation. Published by Mosby, Inc.
Entities:
Keywords:
Severe Asthma Research Program; cluster analysis; eosinophils; neutrophils; phenotype; severe asthma; sputum
Authors: Aaron Deykin; Stephen C Lazarus; John V Fahy; Michael E Wechsler; Homer A Boushey; Vernon M Chinchilli; Timothy J Craig; Emily Dimango; Monica Kraft; Frank Leone; Robert F Lemanske; Richard J Martin; Gene R Pesola; Stephen P Peters; Christine A Sorkness; Stanley J Szefler; Elliot Israel Journal: J Allergy Clin Immunol Date: 2005-04 Impact factor: 10.793
Authors: Wendy C Moore; Eugene R Bleecker; Douglas Curran-Everett; Serpil C Erzurum; Bill T Ameredes; Leonard Bacharier; William J Calhoun; Mario Castro; Kian Fan Chung; Melissa P Clark; Raed A Dweik; Anne M Fitzpatrick; Benjamin Gaston; Mark Hew; Iftikhar Hussain; Nizar N Jarjour; Elliot Israel; Bruce D Levy; James R Murphy; Stephen P Peters; W Gerald Teague; Deborah A Meyers; William W Busse; Sally E Wenzel Journal: J Allergy Clin Immunol Date: 2007-02 Impact factor: 10.793
Authors: Allan R Brasier; Sundar Victor; Gary Boetticher; Hyunsu Ju; Chang Lee; Eugene R Bleecker; Mario Castro; William W Busse; William J Calhoun Journal: J Allergy Clin Immunol Date: 2008-01 Impact factor: 10.793
Authors: E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar Journal: Eur Respir J Date: 2008-01 Impact factor: 16.671
Authors: Annette T Hastie; Wendy C Moore; Huashi Li; Brian M Rector; Victor E Ortega; Rodolfo M Pascual; Stephen P Peters; Deborah A Meyers; Eugene R Bleecker Journal: J Allergy Clin Immunol Date: 2013-05-21 Impact factor: 10.793
Authors: Pranab Haldar; Ian D Pavord; Ruth H Green; Dominic E Shaw; Michael A Berry; Michael Thomas; Christopher E Brightling; Andrew J Wardlaw Journal: Am J Respir Crit Care Med Date: 2008-05-14 Impact factor: 21.405
Authors: Jodie L Simpson; Heather Powell; Michael J Boyle; Rodney J Scott; Peter G Gibson Journal: Am J Respir Crit Care Med Date: 2007-10-18 Impact factor: 21.405
Authors: David W Denning; B Ronan O'Driscoll; Georgina Powell; Fiona Chew; Graham T Atherton; Aashish Vyas; John Miles; Julie Morris; Robert M Niven Journal: Am J Respir Crit Care Med Date: 2008-10-23 Impact factor: 21.405
Authors: Anneke ten Brinke; Aeilko H Zwinderman; Peter J Sterk; Klaus F Rabe; Elisabeth H Bel Journal: Am J Respir Crit Care Med Date: 2004-06-23 Impact factor: 21.405
Authors: F M C Silva; E E Oliveira; A C C Gouveia; A S S Brugiolo; C C Alves; J O A Correa; J Gameiro; J Mattes; H C Teixeira; A P Ferreira Journal: Clin Exp Immunol Date: 2017-03-31 Impact factor: 4.330
Authors: Sanghun Choi; Eric A Hoffman; Sally E Wenzel; Mario Castro; Sean Fain; Nizar Jarjour; Mark L Schiebler; Kun Chen; Ching-Long Lin Journal: J Allergy Clin Immunol Date: 2017-01-29 Impact factor: 10.793
Authors: Matthew S Godwin; Kristen M Reeder; Jaleesa M Garth; Jonathan P Blackburn; MaryJane Jones; Zhihong Yu; Sadis Matalon; Annette T Hastie; Deborah A Meyers; Chad Steele Journal: JCI Insight Date: 2019-11-01
Authors: Anne M Fitzpatrick; Susan T Stephenson; Milton R Brown; Khristopher Nguyen; Shaneka Douglas; Lou Ann S Brown Journal: J Allergy Clin Immunol Pract Date: 2016-09-21
Authors: Kavita Pal; Xin Feng; John W Steinke; Marie D Burdick; Yun M Shim; Sun-Sang Sung; W Gerald Teague; Larry Borish Journal: Am J Respir Cell Mol Biol Date: 2019-04 Impact factor: 6.914